NA
CNMD icon

NewEdge Advisors’s CONMED CNMD Stock Holding History

NewEdge Advisors’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2
Closed -$104 – 4124
2025
Q2 		$104 Sell
2
-10
-83% -$549 ﹤0.01% 3903
2025
Q1 		$725 Hold
12
– – ﹤0.01% 3663
2024
Q4 		$821 Hold
12
– – ﹤0.01% 3594
2024
Q3 		$863 Hold
12
– – ﹤0.01% 3539
2024
Q2 		$832 Hold
12
– – ﹤0.01% 3504
2024
Q1 		$961 Hold
12
– – ﹤0.01% 3506
2023
Q4 		$1.31K Buy
+12
New +$1.24K ﹤0.01% 3413
2023
Q1 		– Sell
-10
Closed -$886 – 3545
2022
Q4 		$886 Buy
+10
New +$830 ﹤0.01% 3064

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

NewEdge Advisors's CNMD Position: Q3 2025 in Review

NewEdge Advisors sold out of CONMED (CNMD) in Q3 2025, closing a stake of 2 shares — an estimated $104 sold.

NewEdge Advisors first reported a position in CNMD in Q4 2022 and held it in 8 quarters. The position peaked at $1.31K in Q4 2023. 273 funds tracked by Wall St. Rank hold CNMD as of Q3 2025.

  • NewEdge Advisors reported no remaining CONMED position as of Q3 2025 after selling out during the quarter.
  • NewEdge Advisors sold 2 CONMED shares in Q3 2025, an estimated $104.
  • NewEdge Advisors first reported a position in CONMED in Q4 2022 and held it in 8 quarters.
  • NewEdge Advisors's CONMED position peaked at $1.31K in Q4 2023.
  • 273 funds tracked by Wall St. Rank held CONMED as of Q3 2025.

Based on NewEdge Advisors's 13F filing for Q3 2025, filed 17 Nov 2025.